Stiles, Brendon M.

TGF-β IL-6 axis mediates selective and adaptive mechanisms of resistance to molecular targeted therapy in lung cancer

Yao, Z., Fenoglio, S., Gao, D. C., Camiolo, M., Stiles, B., Lindsted, T., Schlederer, M., Johns, C., Altorki, N., Mittal, V., et al. (2010) · Proceedings of the National Academy of Sciences

Lung Cancer Treatments and MutationsTGF-β signaling in diseases

Cited by 389

Neoadjuvant durvalumab with or without stereotactic body radiotherapy in patients with early-stage non-small-cell lung cancer: a single-centre, randomised phase 2 trial

Altorki, N. K., McGraw, T. E., Borczuk, A. C., Saxena, A., Port, J. L., Stiles, B. M., Lee, B. E., Sanfilippo, N. J., Scheff, R. J., Pua, B. B., et al. (2021) · The Lancet Oncology

Lung Cancer Diagnosis and TreatmentCancer Immunotherapy and Biomarkers

Cited by 342

Stereotactic body radiotherapy for early-stage non-small-cell lung cancer: American society of clinical oncology endorsement of the American society for radiation oncology evidence-based guideline

Schneider, B. J., Daly, M. E., Kennedy, E. B., Antonoff, M. B., Broderick, S., Feldman, J., Jolly, S., Meyers, B., Rocco, G., Rusthoven, C., et al. (2018) · Journal of Clinical Oncology

Lung Cancer Diagnosis and TreatmentAdvanced Radiotherapy Techniques

Cited by 192

Social Media and Your Cancer Patient

Stiles, B. M., & Mynard, J. N. (2021) · Seminars in Thoracic and Cardiovascular Surgery

Social Media in Health EducationHealth Literacy and Information Accessibility

Cited by 17